Edesa Biotech, Inc. (EDSA) — 10-Q Filings

10-Q Filings (6)

• Edesa Biotech Relies on CEO for Funding Amidst Zero Revenue — Aug 8, 2025 Risk: high
  Edesa Biotech, Inc. reported no revenue for the three and nine months ended June 30, 2025, consistent with the prior year periods, as the company remains in the
• Edesa Biotech Files Q2 2025 10-Q — May 14, 2025 Risk: medium
  Edesa Biotech, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations.
• Edesa Biotech: Series B1 Purchase Agreement Filed — Feb 14, 2025 Risk: medium
  Edesa Biotech, Inc. filed its 10-Q for the period ending December 31, 2024. A significant subsequent event occurred on February 12, 2025, involving a Series B1
• Edesa Biotech Files Q3 2024 10-Q Report — Aug 9, 2024 Risk: medium
  Edesa Biotech, Inc. filed its Q3 2024 10-Q report on August 9, 2024, covering the period ending June 30, 2024. The company, formerly known as Stellar Biotechnol
• Edesa Biotech, Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: medium
  Edesa Biotech, Inc. (EDSA) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Edesa Biotech reported revenue of $3,215,968 for the six months ended M
• Edesa Biotech, Inc. Files 10-Q for Period Ending December 31, 2023 — Feb 9, 2024 Risk: medium
  Edesa Biotech, Inc. (EDSA) filed a Quarterly Report (10-Q) with the SEC on February 9, 2024. Edesa Biotech reported revenue of $3,164,722 for the three months e

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX